Author:
Müller Thomas,Tolosa Eduardo,Badea Letitia,Asgharnejad Mahnaz,Grieger Frank,Markowitz Michael,Nondonfaz Xavier,Bauer Lars,Timmermann Lars
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference24 articles.
1. Ahlskog JE, Muenter MD (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16:448–458
2. Antonini A, Poewe W (2007) Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson’s disease. Lancet Neurol 6:826–829
3. Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311:1670–1683
4. Eggert K, Antony G, Anvari K, Behrens S, Dapprich M, Ehret R, Luerr W, Nass A, Pfister RM, Planz-Kuhlendahl S, Reifschneider G, Simonow A, Schwalbe M, Oertel WH (2016) A prospective, multicenter, 2-year echocardiographic study on valvular heart disease in Parkinson’s disease patients taking rotigotine and other non-ergot dopamine agonists. J Alzheimer’s Dis Parkinsonism 6:233
5. Elmer LW, Surmann E, Boroojerdi B, Jankovic J (2012) Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: a prospective, open-label extension study. Parkinsonism Relat Disord 18:488–493
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献